PSILOCYBIN
Clinical trials for PSILOCYBIN explained in plain language.
Never miss a new study
Get alerted when new PSILOCYBIN trials appear
Sign up with your email to follow new studies for PSILOCYBIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Psychedelic therapy aims to break the relapse cycle in alcoholism and depression
Disease control Recruiting nowThis phase 3 trial investigates whether high-dose psilocybin, given alongside psychotherapy, can prevent relapse in people with severe alcohol use disorder who also have depressive symptoms. Participants receive either a high dose (25 mg) or a low dose (3 mg) of psilocybin in two…
Matched conditions: PSILOCYBIN
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jul 01, 2026 21:00 UTC
-
Magic mushroom compound may rewire the brain for happiness
Knowledge-focused Recruiting nowThis study tests whether psilocybin, the active ingredient in magic mushrooms, can improve emotional wellbeing by promoting brain plasticity. Sixty adults with mild emotional decline will receive different doses of psilocybin, sometimes combined with a drug that causes temporary …
Matched conditions: PSILOCYBIN
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC